Neimeth International Pharmaceuticals Plc (NEIMETH)
About
Neimeth International Pharmaceuticals Plc is a Nigerian pharmaceutical company that manufactures and markets a wide range of pharmaceutical products.
No Asset Insights Available
There’s no available data for this asset at the moment.
Earnings Per Share (EPS)
0.2
The net profit divided by number of shares TTM
Price to Earnings (P/E)
34.43
Current price divided by EPS
Observed Effective Yield
28.89%
Observed annual compounding rate (5y)
Dividend Yield: 0%
0% Payments Since Oct 30th
Dividend history found below or visit Dividend Corner page
Risk Exposure
41.7%
Observed Likelihood of Downside Risk
Risk-Return Ratio
1.76%
You want this to be as low as possible
Periodic Returns
Performance over fixed intervals
DOD(Last Day)
-1.45%
WTD(This Week)
-4.23%
WOW(One Week)
-10.53%
MTD(This Month)
-11.69%
MOM(One Month)
-12.82%
QTD(This Quarter)
-11.69%
QOQ(One Quarter)
-20.00%
YTD(This Year)
17.24%
YOY(One Year)
18.06%
AI-Powered Analysis
Our proprietary engine has identified key patterns and trends for NEIMETH.Sign in to unlock comprehensive analysis and actionable recommendations.
Price Statistics
Analysis from Oct 30, 2025 to Present
Starting
₦5.76
Period High
₦14.7
Period Low
₦4.95
Current
₦6.8
Price Percentile
18.97%